Other Viruses Citation List: May 10 - May 23, 2013
Hepatitis C Virus
1. Thromboxane A2 Synthase Inhibitors Prevent Production of Infectious Hepatitis C Virus in Mice with Humanized Livers. Abe, Y., H.H. Aly, N. Hiraga, M. Imamura, T. Wakita, K. Shimotohno, K. Chayama, and M. Hijikata. Gastroenterology, 2013. [Epub ahead of print]; PMID[23684750].
[PubMed] OV_0510-052313.
2. Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease. Jiang, Y., S.W. Andrews, K. Condroski, B. Buckman, V. Serebryany, S. Wenglowsky, A. Kennedey, M. Madduru, B. Wang, M. Lyon, G. Doherty, B. Woodard, C. Lemieux, M.G. Do, H. Zhang, J.A. Ballard, G. Vigers, B. Brandhuber, P. Stengel, J. Josey, L. Beigelman, L. Blatt, and S.D. Seiwert. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[23672640].
[PubMed] OV_0510-052313.
3. Analogs Design, Synthesis and Biological Evaluation of Peptidomimetics with Potential anti-HCV Activity. Lasheen, D.S., M.A. Ismail, D.A. Abou El Ella, N.S. Ismail, S. Eid, S. Vleck, J.S. Glenn, A.G. Watts, and K.A. Abouzid. Bioorganic & Medicinal Chemistry, 2013. 21(10): p. 2742-2755; PMID[23583031].
[PubMed] OV_0510-052313.
4. Discovery of a Potent Boronic acid Derived Inhibitor of the HCV RNA-dependent RNA Polymerase. Maynard, A., R.M. Crosby, B. Ellis, R. Hamatake, Z. Hong, B.A. Johns, K.M. Kahler, C. Koble, A.L. Leivers, M.R. Leivers, A. Mathis, A.J. Peat, J.J. Pouliot, C.D. Roberts, V. Samano, R.M. Schmidt, G.K. Smith, A. Spaltenstein, E.L. Stewart, P. Thommes, E.M. Turner, C. Voitenleitner, J.T. Walker, G. Waitt, J. Weatherhead, K.L. Weaver, S. Williams, L. Wright, Z.Z. Xiong, D. Haigh, and J.B. Shotwell. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[23672667].
[PubMed] OV_0510-052313.
5. Resistance Mutations against HCV Protease Inhibitors and Antiviral Drug Design. Shang, L., K. Lin, and Z. Yin. Current Pharmaceutical Design, 2013. [Epub ahead of print]; PMID[23688081].
[PubMed] OV_0510-052313.
6. Development of Oleanane-type Triterpenes as a New Class of HCV Entry Inhibitors. Yu, F., Q. Wang, Z. Zhang, Y.Y. Peng, Y.Y. Qiu, Y.Y. Shi, Y.X. Zheng, S.L. Xiao, H. Wang, X.X. Huang, L. Zhu, K.B. Chen, C.K. Zhao, C.L. Zhang, M.R. Yu, D.A. Sun, L.H. Zhang, and D.M. Zhou. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[23662817].
[PubMed] OV_0510-052313.
Human Cytomegalovirus
7. Synthesis and Antiviral Activity of Methylenecyclopropane Analogs with 6-Alkoxy and 6-Alkylthio Substitutions that Exhibit Broad Spectrum Antiviral Activity against Human Herpesviruses. Prichard, M.N., J.D. Williams, G. Komazin-Meredith, A.R. Khan, N.B. Price, G.M. Jefferson, E.A. Harden, C.B. Hartline, N.P. Peet, and T.L. Bowlin. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]; PMID[23669381].
[PubMed] OV_0510-052313.
Citations from the ISI Web of Knowledge Listings for O.V.
8. Recent Progress in Biological Activities and Synthetic Methodologies of Pyrroloquinoxalines. Huang, A.P. and C. Ma. Mini-reviews in Medicinal Chemistry, 2013. 13(4): p. 607-616; ISI[000317209300012].
[WOS] OV_0510-052313.
9. Antiviral Efficacy of a Short PNA Targeting MicroRNA-122 Using Galactosylated Cationic Liposome as a Carrier for the Delivery of the PNA-DNA Hybrid to Hepatocytes. Kim, H., K.H. Lee, K.B. Kim, Y.S. Park, K.S. Kim, and D.E. Kim. Bulletin of the Korean Chemical Society, 2013. 34(3): p. 735-742; ISI[000317168200009].
[WOS] OV_0510-052313.
10. A Cyclic Peptide Mimic of an RNA Recognition Motif of Human LA Protein Is a Potent Inhibitor of Hepatitis C Virus. Manna, A.K., A. Kumar, U. Ray, S. Das, G. Basu, and S. Roy. Antiviral Research, 2013. 97(3): p. 223-226; ISI[000317709400001].
[WOS] OV_0510-052313.
11. Anti-Hepatitis B Virus Activity of Alpha-DDB-DU, a Novel Nucleoside Analogue, in Vitro and in Vivo. Zheng, L.Y., L.M. Zang, Q.H. Yang, W.Q. Yu, X.Z. Fang, Y.H. Zhang, X.J. Zhao, N. Wan, Y.T. Zhang, Q.D. Wang, and J.B. Chang. European Journal of Pharmacology, 2013. 702(1-3): p. 258-263; ISI[000317153100033].
[WOS] OV_0510-052313.